The Angel Academe EIS Fund, managed by SyndicateRoom, today announces its second investment: a significant stake in LabCycle, the UK’s first circular economy solution for laboratory plastic waste.
Founded by a team of female scientists, LabCycle addresses an often-overlooked environmental crisis within the life sciences sector. Research indicates that research and clinical labs produce an estimated 5.5 million tonnes of plastic waste annually.
As Tom Britton, Partner at SyndicateRoom adds, “Plastic waste from bio and clinical labs accounts for nearly 1.5% of total global plastic waste. Backing LabCycle is backing a company solving a multi-billion pound logistics and sustainability problem for the entire life sciences industry.” Historically, this high-grade plastic has been sent to a landfill or incinerated due to decontamination complexities.
LabCycle’s proprietary technology transforms this waste into high-grade recycled plastic pellets, enabling a true circular economy for the healthcare and biotech industries. This investment reinforces the Angel Academe EIS Fund’s commitment to backing exceptional female-led innovation with significant structural impact.
LabCycle have announced the completion of their investment round, including investment from members of the Angel Academe syndicate as well as the Angel Academe EIS fund. Chris Connely, who led the deal team for Angel Academe, noted that “Research and healthcare organisations generate vast volumes of contaminated waste that only Labcycle can recycle, reducing both carbon emissions and cost. Angel Academe are delighted to be a part of the journey, backing a brilliant team and technology”.
The Angel Academe EIS Fund is part of SyndicateRoom’s broader mission to provide sophisticated investors with access to highly curated, tax-efficient venture capital investment opportunities in female-founded startups.
Helen Liang, Co-founder and CEO of LabCycle, said that “It’s been hugely encouraging to work with investors who bring genuine conviction, thoughtful challenge and strong support for founders. Angel Academe and SyndicateRoom have backed both the urgency of the problem and the strength of our team, and we’re excited to have them alongside us as we scale LabCycle and transform how research and healthcare industries handle plastic waste.”
While the current Angel Academe EIS fund is now closed to new investors, this deal illustrates the rigorous selection process applied across all SyndicateRoom-managed funds. Investors looking to gain exposure to similar high-impact sectors ahead of the 5 April tax deadline can see similar EIS and SEIS eligible opportunities at www.syndicateroom.com
